International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct

PURPOSE: To compare cisplatin plus fluorouracil (FU) versus carboplatin plus paclitaxel in chemotherapy-naïve advanced anal cancer to establish the optimal regimen. PATIENTS AND METHODS: Patients who had not received systemic therapy for advanced anal cancer were randomly assigned 1:1 to intravenous...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Rao, Sheela, Sclafani, Francesco, Eng, Cathy, Adams, Richard A., Guren, Marianne G., Sebag-Montefiore, David, Benson, Al, Bryant, Annette, Peckitt, Clare, Segelov, Eva, Roy, Amitesh, Seymour, Matt T., Welch, Jack, Saunders, Mark P., Muirhead, Rebecca, O’Dwyer, Peter, Bridgewater, John, Bhide, Shree, Glynne-Jones, Rob, Arnold, Dirk, Cunningham, David
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7406334/
https://ncbi.nlm.nih.gov/pubmed/32530769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.03266
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados